Interestingly, although there is evidence of MET fusions enriched in gliomas, including one report of ~10% prevalence in pediatric glioblastoma36 and one of 214 fusions detected from 272 glioma samples with RNA‐seq,37 none of the 66 screened gliomas patients in this study was MET+. Here, MET is linked to central nervous system cancer.